Summary of Giant Biogene Holding Co Ltd (2367.HK) Conference Call Company Overview - **Company**: Giant Biogene Holding Co Ltd (2367.HK) - **Industry**: Consumer (Biotech and Skincare) - **Market Cap**: US$6,931.1 million - **Current Stock Price**: HK$53.95 - **Price Target**: HK$78.00, representing a 45% upside from the current price [7][21] Key Financial Highlights - **1H Results**: - Sales increased by 23% - Net Profit (NP) rose by 20% - Operating Profit (OP) was approximately 5% above market expectations [2][3] - **Sales Growth Forecast**: - 2025: 25% increase - 2026: 27% increase - 2027: 27% increase [12][15] - **Net Profit Growth Forecast**: - 2025: 18% - 2026: 24% - 2027: 27% [15] Marketing and Sales Strategy - **Marketing Efficiency**: Improvement noted in 1H results, with a decline in Advertising & Promotion (A&P) expenses for the first time on a semiannual basis [4] - **Sales Channels**: - Online sales grew by 25% - Offline sales increased by 18% - JD Health saw a significant growth of 134% [3] - **KOL Livestreaming Impact**: Temporary disruption due to unfavorable publicity, but recovery is expected [4] Strategic Direction - **In-house Livestreaming**: Shift towards strengthening in-house livestreaming and diversifying influencer partnerships [4] - **Product Innovation**: Emphasis on R&D and product innovation as a competitive advantage [5] Valuation and Price Target Changes - **Price Target Increase**: From HK$74 to HK$78 based on higher EPS estimates [16] - **Valuation Metrics**: - Target P/E remains at 30x for 2025 estimates - Bull-case scenario suggests a target of HK$91.00 with a P/E of 33x [21][29] - Bear-case scenario suggests a target of HK$45.00 with a P/E of 19x [17][31] Risks and Opportunities - **Opportunities**: - Potential growth in aesthetics products not yet priced in - Expected strong sales growth driven by core brands and new product approvals [25][35] - **Risks**: - Competition in the industry may impact margins - Delays in the approval of new aesthetic products could hinder growth [36] Conclusion - **Investment Thesis**: The company is positioned well within the biotech market with a strong growth outlook, driven by innovative products and effective marketing strategies. The current stock price presents an attractive entry point for long-term investors, with significant upside potential as the market begins to recognize the value of its aesthetic product offerings [25][21]

Summary of Midea Group Conference Call Company Overview - **Company**: Midea Group - **Industry**: Home Appliances and Technology Solutions Key Points Business Performance - Midea Group's B-end business revenue reached 32.3 billion yuan in Q2 2025, accounting for approximately 25% of total revenue, with a year-on-year growth of 16.6%, surpassing the C-end home appliance business growth of 9.3% [2][3] - The growth rates for specific segments include Building Technology at 25%, Industrial Technology at 15%, and Robotics at a high single-digit percentage [2][3] - Midea has made significant breakthroughs in the new energy sector, achieving large-scale commercial use of containerized energy storage systems through acquisitions [2][3] Market Concerns - There are concerns regarding Midea's domestic sales due to high base effects and a potential decline in the domestic market in 2026 [2][5] - The overseas market also faces uncertainties, particularly after the inventory replenishment cycle in Europe and the US [5][6] Real Estate Market Insights - The US real estate market is experiencing a supply shortage, with high interest rates suppressing transaction volumes while prices continue to rise [7] - A potential decline in interest rates could lead to a recovery in the real estate market, positively impacting related industries such as tools and home appliances [7] Emerging Market Opportunities - The air conditioning market in emerging countries is rapidly growing, similar to China's market 20 years ago, with low penetration rates in regions like Europe, Southeast Asia, and South America [8] - Midea's strategy of transitioning from an OEM model to developing its own brands has strengthened its competitive position in these markets [9] Stock Performance and Valuation - Midea's stock price has shown a disconnection from its fundamentals since 2023, with significant price increases in 2024 despite underlying challenges [10] - The current valuation of Midea is approximately 13 times earnings, primarily reflecting its consumer goods segment, with potential for revaluation if B-end business is separately valued [4] Investment Considerations - Midea's stock is currently at a low valuation with a significant dividend yield, making it an attractive investment opportunity [15] - The inflow of funds into ETFs and growth-oriented funds has influenced the valuation of the white goods sector, with Midea benefiting from this trend [12][14] Additional Insights - Midea's robotics segment, primarily driven by the acquisition of KUKA, has a domestic market share of 9.4%, but its lower profit margins have led to underappreciation of its B-end business [4] - The company has been focusing on efficiency improvements and brand building through strategic acquisitions, enhancing its market presence in emerging regions [9] Conclusion Midea Group is positioned for growth in both B-end and emerging markets, despite facing challenges in domestic sales and overseas market fluctuations. The company's strategic focus on brand development and efficiency, along with favorable market trends in air conditioning and real estate, presents potential investment opportunities.

Summary of Huiju Technology Conference Call Company Overview - Huiju Technology reported a revenue of HKD 4.9 billion in the first half of 2025, representing an 82% year-on-year increase, with a net profit of HKD 310 million, up 47% year-on-year. The company expects to exceed HKD 10 billion in revenue and achieve a net profit of approximately HKD 650 million for the full year 2025 [2][3][4] - The company is primarily engaged in digital wires, wire components, and server OEM services, with the server business accounting for the largest share (43%) [2][3][4] - The data center-related business contributes over 60% of total revenue, benefiting from the growing demand for AI computing power [2][3][4] Core Business Highlights - The gross margin for special wires is close to 50%, and wire components have higher added value. Revenue from data center wire components, special wires, and server businesses is expected to grow by 100%, 200%, and 40% year-on-year, respectively [2][3][4][12] - The company is controlled by Luxshare Precision, which holds over 70% of its shares, and plans to empower Huiju Technology with AI data center and automotive-related cable businesses [2][3][4][9] - The integration of Leoni K, a German automotive cable company, is expected to contribute approximately HKD 300 million in net profit by 2027, with a long-term net profit margin target of around 5% [2][3][4][13][14] Growth Logic - Huiju Technology's growth logic includes both organic growth and growth from consolidation. The company anticipates revenues of HKD 11 billion, HKD 14 billion, and HKD 16.7 billion from 2025 to 2027, with corresponding growth rates of 50%, 30%, and 20% [6][12] - The expected net profits for the same period are HKD 650 million, HKD 1.1 billion, and HKD 1.4 billion, with growth rates of 40%, 70%, and 30% [6][12] Market Position and Valuation - Huiju Technology is currently the only company in the Hong Kong stock market directly controlled by Luxshare, indicating strong support and collaboration expectations [5][17] - The company has a market capitalization exceeding HKD 28 billion, corresponding to a PE ratio of 43 times, which is considered high given its rapid growth [2][3][5] - The stock has a high expectation gap, with limited institutional coverage prior to September 8, 2023, when it entered the Hong Kong Stock Connect [17][18] Future Outlook - The company is expected to benefit from the increasing demand for AI computing power, particularly from North American clients like Google, which will positively impact its server OEM business [21] - The integration of Leoni K is progressing well, enhancing investor confidence and market expectations [21] - Long-term growth potential remains significant, with expectations for substantial revenue increases in various sectors, including data centers and automotive cables [24] Conclusion - Huiju Technology is positioned for significant growth driven by its strategic focus on high-demand sectors, strong backing from its parent company, and successful integration of new assets. Despite its high valuation, the company's growth prospects and market positioning suggest a favorable investment opportunity [15][19][24]

Summary of the Conference Call Company and Industry Overview - The conference call discusses **Chongqing Mechanical and Electrical Co., Ltd.** and its segments, particularly focusing on the **clean energy equipment** and **high-end intelligent equipment** sectors [2][3][4][6]. Key Points and Arguments Clean Energy Equipment Segment - The clean energy equipment segment is primarily composed of **Chengfei Company** (wind turbine blades) and **Gepai Company** (cables, batteries, etc.) [2][4]. - Wind power generation equipment has the highest revenue share, with significant improvements in gross margins due to enhanced performance in wind turbine equipment [2][3]. - In the first half of 2025, the clean energy equipment segment achieved **revenue of 3.738 billion yuan**, a **year-on-year increase of 11.3%**, with an operating profit of **153 million yuan** [3]. High-end Intelligent Equipment Segment - The high-end intelligent equipment segment includes **intelligent machine tools** and **intelligent manufacturing solutions**, with machine tools having the largest share [6]. - Revenue in this segment grew slightly, but gross margins remained stable due to non-recurring income from the previous year and impairments from overseas subsidiaries [3][6]. Chongqing Cummins Performance - **Chongqing Cummins** reported revenue of approximately **2.5 billion yuan** in the first half of 2025, reflecting a **20% year-on-year growth**, with net profit contributions increasing by **28%** [7]. - The traditional K series engines dominate the product mix, while new models Q19 and Q50 are ramping up production, and Q60's output reached nearly **400 units** in the first half [7][8]. - The engine market share breakdown includes **66%-70%** in the power market and **20%** in the industrial market, with data center products starting to gain traction [8][9]. Operational Efficiency and Cost Management - The company has implemented **lean management** practices to enhance internal efficiency, successfully turning around the hydropower generator business from losses to profitability [11]. - A comprehensive reform plan is in place for the overseas PPG company to optimize its business and capital structure [11][12]. Future Outlook and Strategic Goals - The company aims for stable growth in its Chongqing Cummins business, with expectations of maintaining market share despite high growth rates from the previous year [10]. - The group emphasizes quality improvement over mere revenue growth, focusing on internal order quality and product quality [13]. - There are no immediate plans for asset restructuring, but future strategies may include investments and acquisitions to optimize profitability [16]. Shareholder Returns and Governance - The company has initiated a mid-year dividend in 2025, indicating a shift towards improved shareholder returns [15]. - The local government has issued guidelines for high-quality development, focusing on market value growth and enhanced corporate governance, particularly in ESG aspects [14]. Project Involvement - In the **Yalong River Hydropower Station** project, the company is involved in multiple areas, including hydropower generator components and high-voltage transformer production through its subsidiary [17]. Market Demand and Production Capacity - Chongqing Cummins has a planned production capacity of **23,000 units** for its large-capacity diesel generator sets, with strong market demand reflected in order backlogs [18][19]. - The Q60 model is expected to have a total delivery of **800 units** in 2025, with a balanced order schedule throughout the year [20][21]. Additional Important Information - The localization rate for core components of Chongqing Cummins is approximately **80%-90%**, with some critical parts still imported from the U.S. [23]. - The company is exploring the integration of its products into data centers, including diesel generator sets and cooling systems [26]. - The overall growth outlook for 2025 and beyond remains positive, with detailed forecasts to be completed in the fourth quarter of this year [27].

Summary of Key Points from Conference Call Industry Overview - The new consumption sector in Hong Kong has shown strong performance, with stocks like Pop Mart, Lao Pu Gold, and Mixue Ice City significantly outperforming the Hong Kong Stock Connect Consumption Index and the Wind Consumption Index, primarily driven by young consumers, easing US-China trade tensions, and liquidity injections by the Hong Kong Monetary Authority [2][3][4] - The new consumption sector in Hong Kong has outperformed the A-share market due to a higher concentration of new consumption stocks and a more balanced representation of sub-sectors, capturing new growth points [2][10] Core Insights and Arguments - The new consumption sector's performance is attributed to the young consumer demographic, who prioritize quality-price ratio, emotional value, and social attributes, leading to new consumption trends such as self-indulgent and social consumption [4][5] - Despite a general weakness in consumer sentiment, specific segments within new consumption, such as pet products and educational entertainment, are experiencing rapid growth, with pet food sales increasing by 36% during the 618 shopping festival [7][8] - The current trend in new consumption reflects a dual focus on personalization and rationality, with the Z generation valuing experiences and companionship needs driven by single and elderly demographics [9][11] Financial Performance of Bilibili - Bilibili reported a revenue of 7.3 billion yuan in Q2 2025, a 20% year-on-year increase, with a gross profit of 2.7 billion yuan, reflecting a 46% increase and a gross margin of 36.5% [12][13] - The advertising business accounted for 33% of total revenue, with a significant increase in the number of advertisers, while the gaming segment contributed 22% to the revenue [12][13] - The company is transitioning its valuation from price-to-sales (PS) to price-to-earnings (PE), with adjusted net profit forecasts indicating a return to a reasonable valuation range [12][18] Market Dynamics and Future Outlook - The Hong Kong new consumption sector's total market capitalization exceeds 60%, with revenue growth rates and gross margins outperforming those of the A-share market [4][11] - The anticipated inflow of 300 to 450 billion yuan through the Hong Kong Stock Connect reflects strong interest from domestic public funds in new consumption assets [5][11] - Despite recent adjustments in stock prices, the long-term outlook for new consumption remains positive, driven by ongoing demand for personalized and rational consumption [9][11] Additional Important Insights - The adjustment period from June to August 2025 saw significant declines in representative stocks within the new consumption sector, with average declines around 25%, attributed to previous high valuations and trading volumes [6] - The overall consumer sentiment in China remains weak, with retail sales growth at 5% in the first half of 2025, still below pre-pandemic levels [7] - Bilibili's IP derivative business, while facing short-term pressures, has long-term potential with expected gross margins of 40% to 45% and operating profit margins of 15% to 20% [16] This summary encapsulates the key points from the conference call, highlighting the performance of the new consumption sector, Bilibili's financial results, and the broader market dynamics affecting these trends.

Summary of Dekang Agriculture and Animal Husbandry Conference Call Company Overview - **Company**: Dekang Agriculture and Animal Husbandry - **Industry**: Pig Farming Key Points and Arguments Business Model and Strategy - Dekang has established a low-investment, high-turnover, and high-return farming system by transforming industry challenges into advantages, achieving a pig farming profit of approximately 403 RMB per head in 2024, with ROE and ROIC at 38% and 29% respectively, significantly outperforming peers [2][3] - The company has adopted a "No. 2 Farm" model, which is a light-asset, low-cost, and high-efficiency cooperative farming approach that reduces capital expenditure and enhances production efficiency [2][12] Financial Performance - In 2024, Dekang's total breeding cost is projected to be 13.6 RMB per kilogram, with a slaughter volume increasing from 1.37 million heads in 2020 to 8.78 million heads in 2024, reflecting a compound annual growth rate of 44%, far exceeding the industry average of 0.2% [2][5] - The company has maintained a research and development expense ratio of approximately 1.2% from 2018 to 2024, indicating a strong commitment to breeding innovation [4][10] Breeding and Technology - Since 2013, Dekang has built a core breeding group, introducing advanced breeding technologies and equipment, resulting in a breeding capacity that supports over 30 million piglets [2][6] - The company has achieved significant improvements in breeding efficiency, with a notable reduction in feed-to-meat ratios and earlier market readiness for pigs, enhancing profitability [10] Talent Management and Incentives - Dekang emphasizes talent incentives, with an average salary of 149,000 RMB per employee in 2024, higher than the industry average of 123,000 RMB, and an executive average salary of 810,000 RMB, also above the industry average [7] Future Development Directions - The company plans to continue promoting its light-asset model and enhance its epidemic prevention systems while advancing AI precision farming technologies [8] - Dekang aims to maintain its leading position in biotechnology through ongoing investments in breeding research and development [9] Market Position and Competitive Advantages - Dekang has been recognized for its effective epidemic prevention measures, being designated as a "disease-free zone" by the Ministry of Agriculture in multiple locations since 2021, which supports stable growth [13][14] - The company’s innovative farming model and strong financial performance position it well for future growth, making it a focal point for investors [14] Additional Important Insights - The "No. 2 Farm" model allows for a more efficient production process, with a focus on training and strict entry requirements for farm operators to ensure high-quality output [12] - Dekang's strategic focus on the southwestern region of China, where 7 out of 10 core pig farms are located, has contributed to its competitive edge in the market [5]

Summary of Xiaopeng Motors Conference Call Company Overview - Xiaopeng Motors delivered 197,000 vehicles in the first half of 2025, representing a year-on-year increase of 279% [2][4] - The company achieved a revenue of 18.27 billion yuan in Q2 2025, up 125.3% year-on-year [2][4] - Xiaopeng's gross margin improved significantly, rising from a negative margin in 2023 to 17.3% in Q2 2025, with automotive gross margin at 14.3% [2][5] Strategic Partnerships - Xiaopeng has a strategic partnership with Volkswagen, which includes the development of new vehicles based on the G9 platform and the licensing of the EA architecture [2][6] - The EA architecture licensing is expected to generate high-margin revenue starting in 2027, linked to Volkswagen's sales in China, potentially impacting over 2 million vehicles [6][11] Research and Development - The company maintains a high level of R&D investment, with approximately 4.2 billion yuan spent in the first half of 2025 [2][7] - Despite high R&D spending, the R&D expense ratio is decreasing due to faster revenue growth, which is expected to enhance profitability [7] Future Outlook - Xiaopeng aims to achieve positive net profit attributable to shareholders by Q4 2025, supported by the launch of new products and improved cost control [2][8] - The company plans to introduce five to six new models in 2025, indicating a strong product cycle [8] Product Matrix - Xiaopeng's product lineup includes sedans, MPVs, and SUVs, with models ranging from budget to high-end [9] - The G9 model is positioned in the MPV segment, with a monthly sales volume of approximately 2,000 units [9] Technological Innovations - The introduction of the "Fuyiao" architecture has reduced new vehicle development cycles by 20% and increased parts commonality to 80% [10] - Xiaopeng's self-developed Turing chip has a computing power of over 2000 TOPS, supporting advanced autonomous driving capabilities [12] International Expansion - Xiaopeng has begun sales in Australia, the UK, and Southeast Asia, with plans to introduce more models internationally [14] - The company is also developing humanoid robots and plans to launch an L4 level Robotaxi product by 2026 [13][14] Investment Perspective - Xiaopeng is currently in a strong product cycle with optimistic future sales performance and potential for valuation increase [15]

Summary of Baifengyun Conference Call Company Overview - Baifengyun reported a net profit exceeding 200 million yuan in the first half of 2025, with a net profit margin of 12% and an adjusted margin of 16, indicating strong profitability [2][3] - The company employs approximately 1,400 staff, with 57% in R&D, and an average annual income exceeding 2 million yuan, reflecting a strong emphasis on R&D and high-value talent [2][3] - Baifengyun has served over 8,000 institutions, including banks, internet finance companies, and major internet firms like Alibaba and Baidu, showcasing a broad client base [2][3] Business Structure and Core Advantages - The business is divided into two main segments: Model as a Service (MaaS) and Business as a Service (BaaS) [3] - **MaaS** contributes about one-third of total revenue, providing decision-making support for financial institutions through AI technology, with over 300 million daily calls [2][3][4] - **BaaS** accounts for approximately two-thirds of revenue, utilizing intelligent voice robots for sales and customer operations, relying on generative AI technology [2][3][5] - The launch of the Cyber Star platform aims to enhance internal efficiency across various sectors, significantly reducing contract review times [2][9] Financial Performance - Baifengyun has maintained stable revenue growth of over 20% annually in recent years, with the first half of 2025 exceeding expectations [12] - The BUS financial cloud business saw a 45% year-on-year revenue growth in the first half of 2025, driven by the expansion into broader financial scenarios [14] Market Dynamics and Challenges - The company faces policy uncertainties impacting performance, particularly in the insurance sector, which has shown negative growth since 2024 due to regulatory pressures [13][14] - Despite these challenges, Baifengyun remains optimistic about long-term prospects, having demonstrated resilience in past downturns [13][22] Technological Innovations - The intelligent voice robot technology has proven effective in enhancing customer communication efficiency, with cost reductions to one-fifth of human labor costs and achieving 99% accuracy in voice recognition [7][8] - Baifengyun differentiates itself by utilizing a strong mathematical foundation for user segmentation, focusing on vertical small models rather than general large models [8] Future Outlook - The company plans to continue investing in R&D, with a 30% increase in spending in the first half of 2025, focusing on AIGC and computing clusters [19] - Baifengyun aims to expand its AI business into non-financial sectors, anticipating gradual increases in revenue contribution from these areas [19] Conclusion - Baifengyun is positioned as a resilient player in the AI technology sector, with a commitment to long-term growth despite short-term challenges, maintaining confidence in its strategic direction and market adaptability [22]

Summary of the Conference Call for Sanofi Pharmaceutical Company Overview - Sanofi Pharmaceutical has over 30 years of history, initially founded by General Lou Dan. The company has deep expertise in hematological oncology, nephrology, and consumer healthcare, demonstrating strong resource advantages and sales channel capabilities [3][4]. Core Business Insights - The traditional business remains robust, with the leading product, Teva, expected to exceed 5 billion RMB in sales by 2025 due to expanded indications. The EPO product maintains a leading brand advantage, and the company has developed long-acting second-generation products to mitigate procurement risks [2][9]. - Emerging products like Remage (an anti-itch agent for liver and kidney departments) have entered the medical insurance system and are beginning to scale up, alongside new products like oral paclitaxel contributing to traditional business growth [2][9]. Innovation and Drug Development - Sanofi is actively transforming into an innovative drug company through both internal research and external partnerships. The innovative drug pipeline has made significant progress, particularly with the PDUV bispecific antibody, which has attracted a $6 billion business development agreement with Pfizer, validating its potential [2][4][5][6]. - The PDUV bispecific antibody has shown promising results in early clinical trials for non-small cell lung cancer and colorectal cancer, performing slightly better than comparable products [6]. - The company is also developing PD-1/PD-L1 and PD-1/HER2 bispecific antibodies, which have the potential to become major products in the future [7]. Consumer Healthcare Sector - The consumer healthcare segment is a distinctive growth driver for Sanofi, providing a third growth momentum. The company has made comprehensive and tiered layouts in this area, covering treatments for hair loss, obesity, and skin diseases [10][11]. - The brand "Mandi," which treats hair loss, has established a leading market position, with sales expected to reach several billion RMB in 2024. The introduction of the acne treatment "Velaiva" and the collaboration on the oral weight loss drug "Simei" further enhance the company's consumer healthcare portfolio [11]. Autoimmune Therapy Developments - In the autoimmune field, Sanofi is leveraging its subsidiary Sanjiang Guojian to develop new therapies, including BD ed c two targeting systemic lupus erythematosus and TRY one monoclonal antibody targeting ulcerative colitis, both of which have significant commercialization potential [8][12]. Market Position and Future Outlook - Sanofi's main business has shown steady growth, with a projected growth rate of over 10% in 2024, reflecting its ability to deepen market penetration and build competitive advantages [4][13]. - The company is positioned as a leading player in the domestic innovative pharmaceutical industry, with significant development potential and market value, making it a noteworthy focus for investors [14][15].

Summary of Shangmei Group's Conference Call Company Overview - Shangmei Group's valuation has reached 30 times earnings, exceeding the historical average of 20 times, primarily due to market recognition of its multi-brand development strategy over the next 3-5 years [2][4][15] - The company has experienced significant growth phases since its listing, with a notable increase in valuation from 20 times to 30 times in 2025, driven by its long-term strategy [4][5] Key Points and Arguments Brand Performance - The Han Shu brand previously accounted for over 80% of sales on Douyin, but the company has strategically reduced its investment in direct broadcasting from 50% in 2024 to less than 20% in 2025, shifting focus to live streaming and product card malls [2][7][9] - Despite a short-term impact on GMV, this adjustment has alleviated pressure on profit margins, with GMV data recovering positively from March 2025 [7][9] - Han Shu's growth rate was significant in May and June 2025, maintaining over 50% growth even during the traditionally slower months of July and August [10] Future Growth Strategy - Shangmei Group aims to achieve sales of 20 billion yuan for the Han Shu brand by 2030, positioning it as the leading beauty brand in China through channel and product expansion [11] - The company is diversifying its product categories, with new products accounting for 30%-40% of total offerings, and establishing independent divisions for men's skincare and color cosmetics [8][12] Financial Projections - Expected revenue for 2025 is 8.6 billion yuan, with a net profit of 1.11 billion yuan, corresponding to a current valuation of 30 times earnings; projections for 2026 indicate revenue of 14.3 billion yuan at a valuation of approximately 23-24 times [3][15] - The company has shown strong performance in the first half of 2025, with full-year profit estimates between 1.1 billion and 1.15 billion yuan [15] Emerging Brands - The Yi Ye brand, positioned as a mid-to-high-end domestic product for mothers and infants, has rapidly grown, with a gross margin exceeding 80% and a net margin of over 15%, expected to reach a scale of over 1.5 billion yuan with a net margin of 25% [2][13] - New brands launched in 2025, such as AMU and Ji Fang, have shown promising early performance, contributing to the company's long-term growth strategy [14] Additional Important Insights - The company has made significant adjustments to its channel strategy, focusing on emerging platforms like Kuaishou and traditional e-commerce platforms like Tmall and JD, indicating a clear strategic direction despite reduced investment in direct broadcasting [9] - The upcoming Double Eleven shopping festival is a critical period for the Han Shu brand, where the company plans to leverage its marketing strategies to maximize market opportunities [16]